News | Embolic Protection Devices | July 19, 2019

Filterlex Medical Raises $3 Million in Series A Financing for Embolic Protection Device

Filterlex’s Captis device won Best Innovation Award at EuroPCR 2019

Filterlex Medical Raises $3 Million in Series A Financing for Embolic Protection Device

July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round, raising a total of $3 million for its Captis embolic protection device for reducing the risk of stroke and other complications during catheter-based structural heart procedures. Captis won Best Innovation Award at the EuroPCR 2019 innovation competition in Paris and was awarded a grant of $200,000 by the Jon DeHaan foundation.

During catheter-based, left-heart procedures such as transcatheter aortic valve implantation (TAVI), embolic particles are often released to the blood flow. Particles migration to the brain may cause a spectrum of neurological deficiencies, from cognitive impairment to debilitating stroke. Emboli released to distal organs may result in acute kidney injury and ischemia. The Captis device is a next-generation full-body embolic protection device, easily and intuitively deployed and retrieved. The device is securely positioned in the aorta and protects its surface while facilitating a seamless TAVI procedure. Its triple-action design provides a full-body embolic protection by deflecting, capturing and removing embolic particles. It requires no additional arterial access and does not interfere with the procedure workflow.

For more information: www.filterlex.com


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now